bromodeoxyuridine has been researched along with Vitiligo in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begum, R; Bharti, AH; Dwivedi, M; Giri, PS | 1 |
| Kosaras, B; Ruiz, M; Sidman, RL; Tang, M | 1 |
2 other study(ies) available for bromodeoxyuridine and Vitiligo
| Article | Year |
|---|---|
Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.
Topics: Bromodeoxyuridine; Calcineurin; Calcium; Calcium Channels; CD8-Positive T-Lymphocytes; Forkhead Transcription Factors; Glycogen Synthase Kinase 3 beta; Humans; Interleukin-10; NFATC Transcription Factors; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Vitiligo | 2022 |
Increased cell genesis in retinal pigment epithelium of perinatal vitiligo mutant mice.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Division; DNA; DNA Replication; Female; Image Processing, Computer-Assisted; Kinetics; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mitosis; Morphogenesis; Pigment Epithelium of Eye; Pregnancy; Retinal Degeneration; Vitiligo | 1996 |